Search Results - Ruichao Shi
- Showing 1 - 1 results of 1
-
1
Neoadjuvant therapy with eribulin, doxorubicin and cyclophosphamide for patients with HER2-negative inflammatory breast cancer: a phase II study by Kristina Fanucci, Eren D. Yeh, Ruichao Shi, Lei Qin, Camden P. Bay, Molly DiLullo, Ashka Patel, McKenna Moore, Zachary T. Herbert, Beth T. Harrison, Faina Nakhlis, Jennifer Bellon, Laura Warren, Jennifer L. Guerriero, Sara M. Tolaney, Meredith Regan, Beth Overmoyer, Steven Van Laere, Filipa Lynce
Published in Breast Cancer Research (2025-09-01)Get full text
Article
